Dr. Tayson Delengocky, DO

Dr. Delengocky practices at Surgery Center of California in Chula Vista, California.

Dr. Delengocky's NPI, 1164637153, was assigned on May 11, 2007. Dr. Delengocky graduated from Texas College of Osteopathic Medicine in 2002. Dr. Delengocky holds California license 20A12784.

Dr. Delengocky's primary practice is Surgery Center of California, at 835 3rd Avenue, Suite A, Chula Vista, CA 91911. The practice phone is (619) 425-4209.

Dr. Delengocky's primary practice is Surgery Center of California in Chula Vista, California. Dr. Delengocky is also affiliated with El Centro Regional Medical Center. Dmand AI also links Dr. Delengocky to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delengocky practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Delengocky's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Delengocky is board certified in ophthalmology by the AOA Board of Ophthalmology and Otolaryngology. Dmand AI has Dr. Delengocky's licenses on file in 6 states: California, Texas, Nevada, Illinois, Michigan and New York.

Dmand AI lists age-related macular degeneration, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Delengocky treats.

CMS data shows 8,499 Medicare services from Dr. Delengocky across 21 procedure codes in 2024, for 1,848 Medicare patients. Medicare paid $577,590 for them. Every service was in an office.

CMS counts 1,848 Medicare patients who saw Dr. Delengocky in 2024. The largest group is 65 to 74, with 847 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 80% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delengocky's median patient age at 67, with 56% women.

In 2024, Dr. Delengocky wrote 10,093 Medicare Part D claims for 1,986 patients. 59% of them were for generic drugs. CMS names the drug for 9,990 of them, across 35 drugs with 11 or more claims each, at $1,994,052 in total drug cost. In 2023, CMS named 10,937 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Delengocky for performance year 2024, reported as part of a group. Dr. Delengocky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of cataract surgery by Dr. Delengocky, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Delengocky.

CMS Open Payments shows 177 general payments to Dr. Delengocky from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sun Pharmaceutical Industries Inc. paid the most, $653.

Dmand AI lists 1 award for Dr. Delengocky, most recently Young Physician of the Year in 2011.

Dr. Delengocky graduated from Texas College of Osteopathic Medicine in 2002. Dr. Delengocky is a member of AAO and AOA.

Dr. Delengocky is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.